Invasive aspergillosis in liver transplant recipients: Epidemiology, clinical characteristics, treatment, and outcomes in 116 cases

Invasive aspergillosis (IA) in liver transplant recipients is associated with grave outcomes. We reviewed 116 individual cases reported in the literature from 1985 to 2013. IA was diagnosed after a median of 25 days after transplantation and involved a single organ in 51% of the cases, whereas in th...

Full description

Saved in:
Bibliographic Details
Published inLiver transplantation Vol. 21; no. 2; pp. 204 - 212
Main Authors Barchiesi, Francesco, Mazzocato, Susanna, Mazzanti, Sara, Gesuita, Rosaria, Skrami, Edlira, Fiorentini, Alessandro, Singh, Nina
Format Journal Article
LanguageEnglish
Published United States Wolters Kluwer Health, Inc 01.02.2015
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Invasive aspergillosis (IA) in liver transplant recipients is associated with grave outcomes. We reviewed 116 individual cases reported in the literature from 1985 to 2013. IA was diagnosed after a median of 25 days after transplantation and involved a single organ in 51% of the cases, whereas in the remaining cases, multiple sites were involved. The most common infecting Aspergillus species were Aspergillus fumigatus (73%), Aspergillus flavus (14%), and Aspergillus terreus (8%). Amphotericin B was the drug most frequently used, and it was followed by voriconazole and itraconazole. Combination regimens were used in 51% of the cases. The overall 1‐year cumulative survival probability was 35% [95% confidence interval (CI) = 24.6%‐49.6%]. Survival was significantly higher for patients reported from the year 2000 and thereafter (P < 0.001), for those diagnosed with IA more than 30 days after transplantation versus those diagnosed earlier (P = 0.019), and for patients without renal failure (P = 0.020). Additionally, the use of voriconazole was significantly associated with a higher probability of survival (P < 0.001). Cox regression analysis showed that subjects with the involvement of multiple sites had a 2.52 times higher risk of a negative outcome (95% CI = 1.08‐5.87) than those with the involvement of a single site. Thus, IA causes life‐threatening infections in liver transplant recipients. Predictors associated with poor outcomes may help clinicians to optimize the management of this infection. Liver Transpl 21:204‐212, 2015. © 2014 AASLD.
AbstractList Invasive aspergillosis (IA) in liver transplant recipients is associated with grave outcomes. We reviewed 116 individual cases reported in the literature from 1985 to 2013. IA was diagnosed after a median of 25 days after transplantation and involved a single organ in 51% of the cases, whereas in the remaining cases, multiple sites were involved. The most common infecting Aspergillus species were Aspergillus fumigatus (73%), Aspergillus flavus (14%), and Aspergillus terreus (8%). Amphotericin B was the drug most frequently used, and it was followed by voriconazole and itraconazole. Combination regimens were used in 51% of the cases. The overall 1‐year cumulative survival probability was 35% [95% confidence interval (CI) = 24.6%‐49.6%]. Survival was significantly higher for patients reported from the year 2000 and thereafter ( P  < 0.001), for those diagnosed with IA more than 30 days after transplantation versus those diagnosed earlier ( P  = 0.019), and for patients without renal failure ( P  = 0.020). Additionally, the use of voriconazole was significantly associated with a higher probability of survival ( P  < 0.001). Cox regression analysis showed that subjects with the involvement of multiple sites had a 2.52 times higher risk of a negative outcome (95% CI = 1.08‐5.87) than those with the involvement of a single site. Thus, IA causes life‐threatening infections in liver transplant recipients. Predictors associated with poor outcomes may help clinicians to optimize the management of this infection. Liver Transpl 21:204‐212, 2015 . © 2014 AASLD.
Invasive aspergillosis (IA) in liver transplant recipients is associated with grave outcomes. We reviewed 116 individual cases reported in the literature from 1985 to 2013. IA was diagnosed after a median of 25 days after transplantation and involved a single organ in 51% of the cases, whereas in the remaining cases, multiple sites were involved. The most common infecting Aspergillus species were Aspergillus fumigatus (73%), Aspergillus flavus (14%), and Aspergillus terreus (8%). Amphotericin B was the drug most frequently used, and it was followed by voriconazole and itraconazole. Combination regimens were used in 51% of the cases. The overall 1‐year cumulative survival probability was 35% [95% confidence interval (CI) = 24.6%‐49.6%]. Survival was significantly higher for patients reported from the year 2000 and thereafter (P < 0.001), for those diagnosed with IA more than 30 days after transplantation versus those diagnosed earlier (P = 0.019), and for patients without renal failure (P = 0.020). Additionally, the use of voriconazole was significantly associated with a higher probability of survival (P < 0.001). Cox regression analysis showed that subjects with the involvement of multiple sites had a 2.52 times higher risk of a negative outcome (95% CI = 1.08‐5.87) than those with the involvement of a single site. Thus, IA causes life‐threatening infections in liver transplant recipients. Predictors associated with poor outcomes may help clinicians to optimize the management of this infection. Liver Transpl 21:204‐212, 2015. © 2014 AASLD.
Invasive aspergillosis (IA) in liver transplant recipients is associated with grave outcomes. We reviewed 116 individual cases reported in the literature from 1985 to 2013. IA was diagnosed after a median of 25 days after transplantation and involved a single organ in 51% of the cases, whereas in the remaining cases, multiple sites were involved. The most common infecting Aspergillus species were Aspergillus fumigatus (73%), Aspergillus flavus (14%), and Aspergillus terreus (8%). Amphotericin B was the drug most frequently used, and it was followed by voriconazole and itraconazole. Combination regimens were used in 51% of the cases. The overall 1-year cumulative survival probability was 35% [95% confidence interval (CI) = 24.6%-49.6%]. Survival was significantly higher for patients reported from the year 2000 and thereafter (P < 0.001), for those diagnosed with IA more than 30 days after transplantation versus those diagnosed earlier (P = 0.019), and for patients without renal failure (P = 0.020). Additionally, the use of voriconazole was significantly associated with a higher probability of survival (P < 0.001). Cox regression analysis showed that subjects with the involvement of multiple sites had a 2.52 times higher risk of a negative outcome (95% CI = 1.08-5.87) than those with the involvement of a single site. Thus, IA causes life-threatening infections in liver transplant recipients. Predictors associated with poor outcomes may help clinicians to optimize the management of this infection.
Invasive aspergillosis (IA) in liver transplant recipients is associated with grave outcomes. We reviewed 116 individual cases reported in the literature from 1985 to 2013. IA was diagnosed after a median of 25 days after transplantation and involved a single organ in 51% of the cases, whereas in the remaining cases, multiple sites were involved. The most common infecting Aspergillus species were Aspergillus fumigatus (73%), Aspergillus flavus (14%), and Aspergillus terreus (8%). Amphotericin B was the drug most frequently used, and it was followed by voriconazole and itraconazole. Combination regimens were used in 51% of the cases. The overall 1-year cumulative survival probability was 35% [95% confidence interval (CI) = 24.6%-49.6%]. Survival was significantly higher for patients reported from the year 2000 and thereafter (P < 0.001), for those diagnosed with IA more than 30 days after transplantation versus those diagnosed earlier (P = 0.019), and for patients without renal failure (P = 0.020). Additionally, the use of voriconazole was significantly associated with a higher probability of survival (P < 0.001). Cox regression analysis showed that subjects with the involvement of multiple sites had a 2.52 times higher risk of a negative outcome (95% CI = 1.08-5.87) than those with the involvement of a single site. Thus, IA causes life-threatening infections in liver transplant recipients. Predictors associated with poor outcomes may help clinicians to optimize the management of this infection.Invasive aspergillosis (IA) in liver transplant recipients is associated with grave outcomes. We reviewed 116 individual cases reported in the literature from 1985 to 2013. IA was diagnosed after a median of 25 days after transplantation and involved a single organ in 51% of the cases, whereas in the remaining cases, multiple sites were involved. The most common infecting Aspergillus species were Aspergillus fumigatus (73%), Aspergillus flavus (14%), and Aspergillus terreus (8%). Amphotericin B was the drug most frequently used, and it was followed by voriconazole and itraconazole. Combination regimens were used in 51% of the cases. The overall 1-year cumulative survival probability was 35% [95% confidence interval (CI) = 24.6%-49.6%]. Survival was significantly higher for patients reported from the year 2000 and thereafter (P < 0.001), for those diagnosed with IA more than 30 days after transplantation versus those diagnosed earlier (P = 0.019), and for patients without renal failure (P = 0.020). Additionally, the use of voriconazole was significantly associated with a higher probability of survival (P < 0.001). Cox regression analysis showed that subjects with the involvement of multiple sites had a 2.52 times higher risk of a negative outcome (95% CI = 1.08-5.87) than those with the involvement of a single site. Thus, IA causes life-threatening infections in liver transplant recipients. Predictors associated with poor outcomes may help clinicians to optimize the management of this infection.
Author Singh, Nina
Barchiesi, Francesco
Mazzocato, Susanna
Skrami, Edlira
Mazzanti, Sara
Fiorentini, Alessandro
Gesuita, Rosaria
Author_xml – sequence: 1
  givenname: Francesco
  surname: Barchiesi
  fullname: Barchiesi, Francesco
  organization: Università Politecnica delle Marche
– sequence: 2
  givenname: Susanna
  surname: Mazzocato
  fullname: Mazzocato, Susanna
  organization: Università Politecnica delle Marche
– sequence: 3
  givenname: Sara
  surname: Mazzanti
  fullname: Mazzanti, Sara
  organization: Università Politecnica delle Marche
– sequence: 4
  givenname: Rosaria
  surname: Gesuita
  fullname: Gesuita, Rosaria
  organization: Polytechnic University of Marche
– sequence: 5
  givenname: Edlira
  surname: Skrami
  fullname: Skrami, Edlira
  organization: Polytechnic University of Marche
– sequence: 6
  givenname: Alessandro
  surname: Fiorentini
  fullname: Fiorentini, Alessandro
  organization: Università Politecnica delle Marche
– sequence: 7
  givenname: Nina
  surname: Singh
  fullname: Singh, Nina
  organization: VA Medical Center and University of Pittsburgh
BackLink https://www.ncbi.nlm.nih.gov/pubmed/25348192$$D View this record in MEDLINE/PubMed
BookMark eNp1kcluFDEQhi0URBaQeAJkiQuH6cFrL9xQFCDSSFzC2fK4a0JFbrux3YnmzItjMkmQEJyqyvr-37WckqMQAxDymrM1Z0y892UtFJPiGTnhWnRNqzp59JS3-pic5nzDGOd6YC_IsdBS9XwQJ-TnZbi1GW-B2jxDukbvY8ZMMVBfXxMtyYY8exsKTeBwRgglf6AXM44wYfTxer-izmNAZz11322yrkDCXNDlVZWDLVPVrKgNI41LcXGCe3_OW-pshvySPN9Zn-HVQzwj3z5dXJ1_aTZfP1-ef9w0TtVJmqEbXMsGbnWN1spedJ2uJXd9u7Vy5IMCpWCww6CkYluxdb2EUegdl61jSp6RdwffOcUfC-RiJswOfB0O4pINb7VQoteyrejbv9CbuKRQu6uUqv9yxnWl3jxQy3aC0cwJJ5v25nG9FVgfAJdizgl2xmGxBWOoa0VvODO_72d8Mff3-9Pik-DR8x9oc0Dv0MP-v5zZXB34XwTPqBQ
CODEN LITRFO
CitedBy_id crossref_primary_10_6002_ect_2017_0171
crossref_primary_10_1089_sur_2023_346
crossref_primary_10_1016_j_ijantimicag_2015_05_023
crossref_primary_10_4254_wjh_v7_i14_1828
crossref_primary_10_1186_s12879_018_3617_4
crossref_primary_10_1097_MOT_0000000000000431
crossref_primary_10_1080_1744666X_2018_1476852
crossref_primary_10_1111_ctr_13544
crossref_primary_10_1002_micr_30137
crossref_primary_10_1007_s00595_021_02263_z
crossref_primary_10_1016_j_mycmed_2022_101310
crossref_primary_10_15825_1995_1191_2024_3_56_65
crossref_primary_10_1016_j_anclin_2017_04_002
crossref_primary_10_1099_jmm_0_000233
crossref_primary_10_1111_tid_12898
crossref_primary_10_1111_myc_12469
crossref_primary_10_1080_14656566_2024_2326507
crossref_primary_10_1111_ajt_13837
crossref_primary_10_1016_j_jceh_2023_101316
crossref_primary_10_1177_0300060517729907
crossref_primary_10_1248_bpb_b18_00164
crossref_primary_10_3390_jof9020272
crossref_primary_10_1007_s12281_022_00446_w
crossref_primary_10_1016_j_transproceed_2017_09_013
crossref_primary_10_1002_lt_24365
crossref_primary_10_1111_tid_14049
crossref_primary_10_5812_archcid_138411
crossref_primary_10_1186_s12893_019_0668_4
crossref_primary_10_1007_s00108_015_3807_8
crossref_primary_10_2174_1574886318666221206102653
crossref_primary_10_1007_s40588_015_0017_z
crossref_primary_10_1186_s40792_021_01203_w
crossref_primary_10_1016_j_cmi_2018_01_002
crossref_primary_10_3390_jof7070524
crossref_primary_10_1111_ajt_16935
crossref_primary_10_1007_s00606_016_1331_5
crossref_primary_10_1155_2015_960357
crossref_primary_10_1093_jac_dkz038
crossref_primary_10_1007_s10238_024_01419_8
crossref_primary_10_12998_wjcc_v6_i16_1155
crossref_primary_10_1002_micr_30272
crossref_primary_10_1080_1354750X_2020_1810318
crossref_primary_10_1016_j_mcna_2016_01_008
crossref_primary_10_3389_fimmu_2017_01273
crossref_primary_10_18499_2070_478X_2021_14_1_10_18
crossref_primary_10_3390_jof11010070
crossref_primary_10_7759_cureus_42554
crossref_primary_10_1016_j_gastre_2016_11_017
crossref_primary_10_1097_TP_0000000000004312
crossref_primary_10_1186_s12879_018_3527_5
crossref_primary_10_1007_s00428_025_04050_4
crossref_primary_10_1007_s12281_022_00442_0
crossref_primary_10_1097_GOX_0000000000002041
crossref_primary_10_1007_s00423_019_01769_y
crossref_primary_10_1177_0885066618757410
crossref_primary_10_1097_TP_0000000000005082
crossref_primary_10_3390_jcm12093238
crossref_primary_10_3390_jof9020255
crossref_primary_10_1371_journal_pone_0197319
crossref_primary_10_3390_jcm12041520
crossref_primary_10_5812_jjm_104089
crossref_primary_10_1016_j_gastrohep_2016_11_011
crossref_primary_10_1097_HC9_0000000000000216
crossref_primary_10_2520_myco_65_109
crossref_primary_10_1016_j_jiac_2015_11_005
Cites_doi 10.1093/clinids/13.4.653
10.1111/j.1399-3062.2011.00599.x
10.1182/blood-2007-01-069294
10.1053/jlts.2002.35778
10.1016/j.transproceed.2006.10.015
10.1016/j.transproceed.2007.10.013
10.1136/jcp.43.2.114
10.1093/jac/43.4.597
10.1016/S0168-8278(98)80329-2
10.1086/520297
10.1097/01.tp.0000263336.80146.27
10.1016/0732-8893(92)90074-4
10.1111/j.1399-3062.2004.00039.x
10.1086/525258
10.1378/chest.109.4.1119
10.1093/clinids/23.3.608
10.1212/WNL.42.9.1817
10.1016/S0190-9622(94)70169-5
10.1097/00005792-199903000-00003
10.1016/j.jinf.2012.08.003
10.1111/j.1399-3062.2009.00461.x
10.1093/jac/dkg450
10.1016/j.transproceed.2009.07.008
10.1016/j.transproceed.2004.09.043
10.1086/430602
10.1111/j.1399-3046.2007.00754.x
10.1086/596757
10.1007/BF02114892
10.1111/j.1432-2277.2008.00817.x
10.1111/j.1399-3062.2009.00367.x
10.1111/j.1439-0507.2009.01829.x
10.1086/345441
10.1097/00007890-199602270-00029
10.1016/j.healun.2013.11.003
10.1086/588660
10.1111/j.1399-3062.2008.00323.x
10.4161/viru.1.5.13110
10.1056/NEJMoa020191
10.1016/j.transproceed.2011.05.034
10.1111/ajt.12115
10.1016/j.transproceed.2007.05.085
10.1053/jlts.2002.36239
10.1097/00007890-199709150-00009
10.1111/1469-0691.12409
10.1136/jcp.48.3.210
10.1046/j.1439-0507.1999.00266.x
10.1097/00042737-200012010-00022
10.1097/01.tp.0000202421.94822.f7
10.1086/503427
10.1111/j.1399-3046.2008.00929.x
10.6002/ect.2012.0028
10.1592/phco.26.12.1730
10.1086/513655
10.1111/j.1399-0012.2008.00801.x
10.1016/j.jinf.2006.02.007
10.1093/infdis/166.6.1379
ContentType Journal Article
Copyright 2014 American Association for the Study of Liver Diseases
2014 American Association for the Study of Liver Diseases.
2015 American Association for the Study of Liver Diseases
Copyright_xml – notice: 2014 American Association for the Study of Liver Diseases
– notice: 2014 American Association for the Study of Liver Diseases.
– notice: 2015 American Association for the Study of Liver Diseases
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
K9.
7X8
DOI 10.1002/lt.24032
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic
DatabaseTitleList CrossRef

MEDLINE
MEDLINE - Academic
ProQuest Health & Medical Complete (Alumni)
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1527-6473
EndPage 212
ExternalDocumentID 3566976921
25348192
10_1002_lt_24032
LT24032
Genre article
Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
--K
.3N
.55
.GA
.GJ
.Y3
05W
0R~
10A
1B1
1L6
1OC
1~5
24P
31~
33P
3SF
3WU
4.4
4G.
4ZD
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5GY
5VS
7-5
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAEDT
AAESR
AAEVG
AAHHS
AALRI
AAOCO
AAONW
AAQFI
AAQXK
AASGY
AAXRX
AAXUO
AAZKR
ABCQN
ABCUV
ABEML
ABIJN
ABJNI
ABLJU
ABMAC
ABPVW
ABWVN
ABXGK
ACAHQ
ACCFJ
ACCZN
ACGFO
ACGFS
ACLDA
ACMXC
ACPOU
ACRPL
ACSCC
ACXBN
ACXQS
ADEOM
ADIZJ
ADKYN
ADMGS
ADMUD
ADNMO
ADOZA
ADXAS
ADZMN
AECAP
AEEZP
AEGXH
AEIMD
AENEX
AEQDE
AEUQT
AFBPY
AFGKR
AFPWT
AFUWQ
AFZJQ
AHMBA
AIACR
AIURR
AIWBW
AJAOE
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AMBMR
AMYDB
ATUGU
AZBYB
AZVAB
BAFTC
BHBCM
BMXJE
BROTX
BRXPI
BY8
C45
CAG
COF
CS3
D-6
D-7
D-E
D-F
DCZOG
DIK
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DU5
E3Z
EBS
EJD
F00
F01
F04
F5P
FD6
FDB
FEDTE
FGOYB
FUBAC
G-S
G.N
GNP
GODZA
H.X
HBH
HF~
HHY
HHZ
HVGLF
HZ~
IHE
IX1
J0M
J5H
JPC
KBYEO
KQQ
LATKE
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
M41
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
NNB
NQ-
O66
O9-
OIG
OK1
OVD
P2W
P2X
P2Z
P4B
P4D
PQQKQ
Q.N
Q11
QB0
QRW
R.K
R2-
RIG
ROL
RPZ
RWI
RX1
SEW
SSZ
SUPJJ
TEORI
UB1
UHS
V2E
V8K
V9Y
W8V
W99
WBKPD
WHWMO
WIH
WIJ
WIK
WIN
WJL
WOHZO
WQJ
WRC
WVDHM
WXI
X7M
XG1
XV2
ZZTAW
~IA
~WT
AAFWJ
AAYXX
ACZKN
AFNMH
AGQPQ
AHQVU
CITATION
MEWTI
WXSBR
ACIJW
CGR
CUY
CVF
ECM
EIF
NPM
AAMMB
ADSXY
AEFGJ
AGXDD
AIDQK
AIDYY
K9.
7X8
ID FETCH-LOGICAL-c4152-979c6091a59c6aa38277591a1c86ba3d194e44e9a994340b2bc83ed25f136c043
IEDL.DBID DR2
ISSN 1527-6465
1527-6473
IngestDate Fri Jul 11 08:02:12 EDT 2025
Wed Aug 13 08:54:00 EDT 2025
Wed Feb 19 01:56:29 EST 2025
Tue Jul 01 00:48:28 EDT 2025
Thu Apr 24 22:53:47 EDT 2025
Wed Jan 22 16:57:55 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 2
Language English
License http://doi.wiley.com/10.1002/tdm_license_1.1
2014 American Association for the Study of Liver Diseases.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c4152-979c6091a59c6aa38277591a1c86ba3d194e44e9a994340b2bc83ed25f136c043
Notes This article is dedicated to Fausto Ancarani, M.D., 1950‐2011.
Potential conflict of interest: Nina Singh has received investigator‐initiated research grant support from Pfizer and Astellas.
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
PMID 25348192
PQID 1647751015
PQPubID 1016400
PageCount 9
ParticipantIDs proquest_miscellaneous_1652428536
proquest_journals_1647751015
pubmed_primary_25348192
crossref_citationtrail_10_1002_lt_24032
crossref_primary_10_1002_lt_24032
wiley_primary_10_1002_lt_24032_LT24032
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate February 2015
PublicationDateYYYYMMDD 2015-02-01
PublicationDate_xml – month: 02
  year: 2015
  text: February 2015
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: Philadelphia
PublicationTitle Liver transplantation
PublicationTitleAlternate Liver Transpl
PublicationYear 2015
Publisher Wolters Kluwer Health, Inc
Publisher_xml – name: Wolters Kluwer Health, Inc
References 2007; 39
2010; 12
1996; 109
2009; 41
1991; 13
1992; 166
2004; 6
1999; 43
2011; 54
1999; 42
2008; 105
2011; 13
1992; 15
2001; 44
2012; 125
2003; 52
2012; 10
2009; 48
2014; 20
2009; 11
1990; 43
2009; 13
2010; 1
2013; 2013
2013; 13
2000; 12
2004; 36
2006; 26
1996; 61
2002; 347
2008; 22
1992; 42
2012; 65
1996; 23
1994; 31
1998; 26
2009; 22
1998; 28
2006; 53
1997; 64
1995; 14
1997; 24
2002; 8
2003; 36
2005; 41
2008; 10
2007; 11
2006; 81
2006; 42
1995; 48
2007; 110
1999; 78
2008; 46
2011; 43
2007; 83
2008; 40
2014; 33
(lt24032-bib-0036-20240115) 2007; 39
(lt24032-bib-0040-20240115) 2008; 40
(lt24032-bib-0026-20240115) 1999; 42
(lt24032-bib-0037-20240115) 2008; 22
(lt24032-bib-0056-20240115) 2004; 36
(lt24032-bib-0028-20240115) 2001; 44
(lt24032-bib-0008-20240115) 1995; 14
(lt24032-bib-0001-20240115) 2013; 13
(lt24032-bib-0019-20240115) 1994; 31
(lt24032-bib-0044-20240115) 2009; 11
(lt24032-bib-0018-20240115) 1992; 42
(lt24032-bib-0030-20240115) 2002; 8
(lt24032-bib-0029-20240115) 2002; 8
(lt24032-bib-0027-20240115) 2000; 12
(lt24032-bib-0051-20240115) 2012; 125
(lt24032-bib-0006-20240115) 1996; 61
(lt24032-bib-0010-20240115) 1996; 23
(lt24032-bib-0032-20240115) 2006; 53
(lt24032-bib-0004-20240115) 2012; 65
(lt24032-bib-0012-20240115) 2002; 347
(lt24032-bib-0042-20240115) 2009; 22
(lt24032-bib-0015-20240115) 1990; 43
(lt24032-bib-0035-20240115) 2007; 83
(lt24032-bib-0002-20240115) 1997; 64
(lt24032-bib-0039-20240115) 2008; 105
(lt24032-bib-0054-20240115) 2006; 26
(lt24032-bib-0003-20240115) 2003; 36
(lt24032-bib-0034-20240115) 2007; 11
(lt24032-bib-0053-20240115) 2006; 42
(lt24032-bib-0052-20240115) 2013; 2013
(lt24032-bib-0060-20240115) 2014; 20
(lt24032-bib-0020-20240115) 1995; 48
(lt24032-bib-0043-20240115) 2009; 13
(lt24032-bib-0050-20240115) 2011; 43
(lt24032-bib-0058-20240115) 2009; 48
(lt24032-bib-0007-20240115) 2005; 41
(lt24032-bib-0033-20240115) 2007; 39
(lt24032-bib-0055-20240115) 2007; 110
(lt24032-bib-0025-20240115) 1999; 43
(lt24032-bib-0014-20240115) 2008; 46
(lt24032-bib-0045-20240115) 2011; 54
(lt24032-bib-0047-20240115) 2010; 12
(lt24032-bib-0057-20240115) 2008; 46
(lt24032-bib-0005-20240115) 1999; 78
(lt24032-bib-0013-20240115) 2006; 81
(lt24032-bib-0016-20240115) 1991; 13
(lt24032-bib-0009-20240115) 1992; 166
(lt24032-bib-0011-20240115) 2003; 52
(lt24032-bib-0038-20240115) 2008; 10
(lt24032-bib-0024-20240115) 1998; 26
(lt24032-bib-0023-20240115) 1998; 28
(lt24032-bib-0041-20240115) 2009; 41
(lt24032-bib-0021-20240115) 1996; 109
(lt24032-bib-0022-20240115) 1997; 24
(lt24032-bib-0049-20240115) 2011; 13
(lt24032-bib-0046-20240115) 2012; 10
(lt24032-bib-0031-20240115) 2004; 6
(lt24032-bib-0048-20240115) 2010; 1
(lt24032-bib-0017-20240115) 1992; 15
(lt24032-bib-0059-20240115) 2014; 33
References_xml – volume: 13
  start-page: 192
  year: 2011
  end-page: 199
  article-title: vertebral osteomyelitis and ureteral obstruction after liver transplantation
  publication-title: Transpl Infect Dis
– volume: 42
  start-page: 1817
  year: 1992
  end-page: 1719
  article-title: Treatment of cerebral aspergillosis after liver transplantation
  publication-title: Neurology
– volume: 48
  start-page: 503
  year: 2009
  end-page: 535
  article-title: Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America
  publication-title: Clin Infect Dis
– volume: 22
  start-page: 508
  year: 2008
  end-page: 511
  article-title: flavus myositis in a patient after liver transplantation
  publication-title: Clin Transplant
– volume: 10
  start-page: 333
  year: 2008
  end-page: 338
  article-title: Real‐time PCR on the first galactomannan‐positive serum sample for diagnosis invasive aspergillosis in liver transplant recipients
  publication-title: Transpl Infect Dis
– volume: 42
  start-page: 1417
  year: 2006
  end-page: 1427
  article-title: Diagnosis of invasive aspergillosis using a galactomannan assay: a meta‐analysis
  publication-title: Clin Infect Dis
– volume: 65
  start-page: 453
  year: 2012
  end-page: 464
  article-title: Clinical epidemiology of 960 patients with invasive aspergillosis from the PATH Alliance registry
  publication-title: J Infect
– volume: 81
  start-page: 320
  year: 2006
  end-page: 326
  article-title: Combination of voriconazole and caspofungin as primary therapy for invasive aspergillosis in solid organ transplant recipients: a prospective, multicenter, observational study
  publication-title: Transplantation
– volume: 2013
  start-page: 928289
  year: 2013
  article-title: tracheobronchitis causing subtotal tracheal stenosis in a liver transplant recipient
  publication-title: Case Rep Transplant
– volume: 13
  start-page: 228
  year: 2013
  end-page: 241
  article-title: Aspergillosis in solid organ transplantation
  publication-title: Am J Transplant
– volume: 64
  start-page: 716
  year: 1997
  end-page: 720
  article-title: Invasive aspergillosis in liver transplant recipients in the 1990s
  publication-title: Transplantation
– volume: 10
  start-page: 482
  year: 2012
  end-page: 486
  article-title: Treatment of refractory cerebral aspergillosis in a liver transplant recipient with voriconazole: case report and review of the literature
  publication-title: Exp Clin Transplant
– volume: 13
  start-page: 636
  year: 2009
  end-page: 640
  article-title: endocarditis in a pediatric liver transplant recipient: favorable outcome without cardiac surgery
  publication-title: Pediatr Transplant
– volume: 23
  start-page: 608
  year: 1996
  end-page: 615
  article-title: Therapeutic outcome in invasive aspergillosis
  publication-title: Clin Infect Dis
– volume: 125
  start-page: 2772
  year: 2012
  end-page: 2774
  article-title: Primary spondylodiscitis in a liver transplant recipient
  publication-title: Chin Med J (Engl)
– volume: 43
  start-page: 2428
  year: 2011
  end-page: 2430
  article-title: Invasive pulmonary aspergillosis after living donor liver transplantation should be eradicated or not? A case report
  publication-title: Transplant Proc
– volume: 43
  start-page: 597
  year: 1999
  end-page: 600
  article-title: Fungal infection and liposomal amphotericin B (AmBisome) therapy in liver transplantation: a 2 year review
  publication-title: J Antimicrob Chemother
– volume: 11
  start-page: 868
  year: 2007
  end-page: 875
  article-title: Aspergillosis in children after liver transplantation: single center experience
  publication-title: Pediatr Transplant
– volume: 28
  start-page: 518
  year: 1998
  end-page: 522
  article-title: Cerebral aspergillosis in a liver transplant recipient: a case report of long term survival after combined treatment with liposomal amphotericin B and surgery
  publication-title: J Hepatol
– volume: 53
  start-page: e231
  year: 2006
  end-page: e233
  article-title: thyroiditis in a living donor liver transplant recipient
  publication-title: J Infect
– volume: 26
  start-page: 1092
  year: 1998
  end-page: 1097
  article-title: Invasive pulmonary aspergillosis due to : 12‐year experience and review of the literature
  publication-title: Clin Infect Dis
– volume: 24
  start-page: 1172
  year: 1997
  end-page: 1177
  article-title: Infectious ocular complications in orthotopic liver transplant patients
  publication-title: Clin Infect Dis
– volume: 26
  start-page: 1730
  year: 2006
  end-page: 1744
  article-title: Factors influencing the magnitude and clinical significance of drug interactions between azole antifungals and select immunosuppressants
  publication-title: Pharmacotherapy
– volume: 46
  start-page: 327
  year: 2008
  end-page: 360
  article-title: Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America
  publication-title: Clin Infect Dis
– volume: 12
  start-page: 51
  year: 2010
  end-page: 53
  article-title: Severe cerebral aspergillosis after liver transplant
  publication-title: Transpl Infect Dis
– volume: 42
  start-page: 47
  year: 1999
  end-page: 53
  article-title: Systemic mycoses during prophylactical use of liposomal amphotericin B (Ambisome) after liver transplantation
  publication-title: Mycoses
– volume: 1
  start-page: 465
  year: 2010
  end-page: 467
  article-title: Successful, combined long‐term treatment of cerebral aspergillosis in a liver transplant patient
  publication-title: Virulence
– volume: 12
  start-page: 123
  year: 2000
  end-page: 126
  article-title: osteomyelitis after liver transplantation: conservative or surgical treatment?
  publication-title: Eur J Gastroenterol Hepatol
– volume: 110
  start-page: 490
  year: 2007
  end-page: 500
  article-title: Sirolimus‐based graft‐versus‐host disease prophylaxis protects against cytomegalovirus reactivation after allogeneic hematopoietic stem cell transplantation: a cohort analysis
  publication-title: Blood
– volume: 41
  start-page: 52
  year: 2005
  end-page: 59
  article-title: Risk factors for invasive aspergillosis in solid‐organ transplant recipients: a case‐control study
  publication-title: Clin Infect Dis
– volume: 48
  start-page: 210
  year: 1995
  end-page: 213
  article-title: Use of the Pastorex antigen latex agglutination test for the diagnosis of invasive aspergillosis
  publication-title: J Clin Pathol
– volume: 54
  start-page: e220
  year: 2011
  end-page: e222
  article-title: Invasive aspergillosis caused by in a living donor liver transplant recipient successfully treated by caspofungin
  publication-title: Mycoses
– volume: 39
  start-page: 3505
  year: 2007
  end-page: 3508
  article-title: A case of successful resection after long‐term medical treatment of invasive pulmonary aspergillosis following living donor liver transplantation
  publication-title: Transplant Proc
– volume: 11
  start-page: 175
  year: 2009
  end-page: 178
  article-title: Invasive aspergillosis in two liver transplant recipients: diagnosis by SeptiFast
  publication-title: Transpl Infect Dis
– volume: 46
  start-page: 1813
  year: 2008
  end-page: 1821
  article-title: Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group
  publication-title: Clin Infect Dis
– volume: 78
  start-page: 123
  year: 1999
  end-page: 138
  article-title: Invasive aspergillosis in transplant recipients
  publication-title: Medicine (Baltimore)
– volume: 43
  start-page: 114
  year: 1990
  end-page: 118
  article-title: Cerebral aspergillosis in liver transplantation
  publication-title: J Clin Pathol
– volume: 166
  start-page: 1379
  year: 1992
  end-page: 1383
  article-title: Factors associated with invasive lung aspergillosis and the significance of positive culture after liver transplantation
  publication-title: J Infect Dis
– volume: 40
  start-page: 1771
  year: 2008
  end-page: 1773
  article-title: Hepatic and renal artery rupture due to and Mucor mixed infection after combined liver and kidney transplantation: a case report
  publication-title: Transplant Proc
– volume: 36
  start-page: 2708
  year: 2004
  end-page: 2709
  article-title: Combined use of sirolimus and voriconazole in renal transplantation: a report of two cases
  publication-title: Transplant Proc
– volume: 31
  start-page: 344
  year: 1994
  end-page: 347
  article-title: Primary cutaneous infection by in a 62‐year‐old liver transplant recipient
  publication-title: J Am Acad Dermatol
– volume: 61
  start-page: 666
  year: 1996
  end-page: 669
  article-title: Incidence and significance of cultures following liver and kidney transplantation
  publication-title: Transplantation
– volume: 109
  start-page: 1119
  year: 1996
  end-page: 1124
  article-title: Transmission of invasive aspergillosis from a subclinically infected donor to three different organ transplant recipients
  publication-title: Chest
– volume: 52
  start-page: 813
  year: 2003
  end-page: 819
  article-title: Prevention of invasive fungal infections in liver transplant recipients: the role of prophylaxis with lipid formulations of amphotericin B in high‐risk patients
  publication-title: J Antimicrob Chemother
– volume: 8
  start-page: 1065
  year: 2002
  end-page: 1070
  article-title: Risk factors for invasive aspergillosis in liver transplant recipients
  publication-title: Liver Transpl
– volume: 39
  start-page: 305
  year: 2007
  end-page: 307
  article-title: Survival after disseminated invasive aspergillosis in a multivisceral transplant recipient
  publication-title: Transplant Proc
– volume: 6
  start-page: 37
  year: 2004
  end-page: 40
  article-title: Deep sinus aspergillosis in a liver transplant recipient successfully treated with a combination of caspofungin and voriconazole
  publication-title: Transpl Infect Dis
– volume: 15
  start-page: 703
  year: 1992
  end-page: 706
  article-title: Surgical wound infection by in liver transplant recipients
  publication-title: Diagn Microbiol Infect Dis
– volume: 36
  start-page: 46
  year: 2003
  end-page: 52
  article-title: Trends in risk profiles for and mortality associated with invasive aspergillosis among liver transplant recipients
  publication-title: Clin Infect Dis
– volume: 14
  start-page: 375
  year: 1995
  end-page: 382
  article-title: Risk factors for systemic fungal infections in liver transplant recipients
  publication-title: Eur J Clin Microbiol Infect Dis
– volume: 20
  start-page: 580
  year: 2014
  end-page: 585
  article-title: Improvement in the outcome of invasive fusariosis in the last decade
  publication-title: Clin Microbiol Infect
– volume: 13
  start-page: 653
  year: 1991
  end-page: 657
  article-title: Aspergillosis of the CNS in a pediatric liver transplant recipient: case report and review
  publication-title: Rev Infect Dis
– volume: 22
  start-page: 589
  year: 2009
  end-page: 591
  article-title: Successful treatment of invasive sphenoidal, pulmonary and intracerebral aspergillosis after multivisceral transplantation
  publication-title: Transpl Int
– volume: 8
  start-page: 1073
  year: 2002
  end-page: 1075
  article-title: osteomyelitis after liver transplantation
  publication-title: Liver Transpl
– volume: 347
  start-page: 408
  year: 2002
  end-page: 415
  article-title: Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis
  publication-title: N Engl J Med
– volume: 83
  start-page: 1408
  year: 2007
  end-page: 1409
  article-title: Successful treatment of invasive pulmonary aspergillosis after ABO‐incompatible living donor liver transplantation under rapid steroid withdrawal protocol
  publication-title: Transplantation
– volume: 105
  start-page: 66
  year: 2008
  end-page: 69
  article-title: Severe endophthalmitis occurring after liver transplantation in an 8‐month‐old baby [in German]
  publication-title: Ophthalmologe
– volume: 33
  start-page: 278
  year: 2014
  end-page: 288
  article-title: Invasive aspergillosis among heart transplant recipients: a 24‐year perspective
  publication-title: J Heart Lung Transplant
– volume: 44
  start-page: 370
  issue: suppl
  year: 2001
  end-page: 372
  article-title: Coexistent cutaneous and cytomegalovirus infection in a liver transplant recipient
  publication-title: J Am Acad Dermatol
– volume: 41
  start-page: 2933
  year: 2009
  end-page: 2935
  article-title: Endogenous endophthalmitis occurring after liver transplantation: a case report
  publication-title: Transplant Proc
– volume: 13
  start-page: 653
  year: 1991
  ident: lt24032-bib-0016-20240115
  article-title: Aspergillosis of the CNS in a pediatric liver transplant recipient: case report and review
  publication-title: Rev Infect Dis
  doi: 10.1093/clinids/13.4.653
– volume: 13
  start-page: 192
  year: 2011
  ident: lt24032-bib-0049-20240115
  article-title: Aspergillus vertebral osteomyelitis and ureteral obstruction after liver transplantation
  publication-title: Transpl Infect Dis
  doi: 10.1111/j.1399-3062.2011.00599.x
– volume: 110
  start-page: 490
  year: 2007
  ident: lt24032-bib-0055-20240115
  article-title: Sirolimus‐based graft‐versus‐host disease prophylaxis protects against cytomegalovirus reactivation after allogeneic hematopoietic stem cell transplantation: a cohort analysis
  publication-title: Blood
  doi: 10.1182/blood-2007-01-069294
– volume: 8
  start-page: 1073
  year: 2002
  ident: lt24032-bib-0029-20240115
  article-title: Aspergillus osteomyelitis after liver transplantation
  publication-title: Liver Transpl
  doi: 10.1053/jlts.2002.35778
– volume: 39
  start-page: 305
  year: 2007
  ident: lt24032-bib-0033-20240115
  article-title: Survival after disseminated invasive aspergillosis in a multivisceral transplant recipient
  publication-title: Transplant Proc
  doi: 10.1016/j.transproceed.2006.10.015
– volume: 40
  start-page: 1771
  year: 2008
  ident: lt24032-bib-0040-20240115
  article-title: Hepatic and renal artery rupture due to Aspergillus and Mucor mixed infection after combined liver and kidney transplantation: a case report
  publication-title: Transplant Proc
  doi: 10.1016/j.transproceed.2007.10.013
– volume: 43
  start-page: 114
  year: 1990
  ident: lt24032-bib-0015-20240115
  article-title: Cerebral aspergillosis in liver transplantation
  publication-title: J Clin Pathol
  doi: 10.1136/jcp.43.2.114
– volume: 43
  start-page: 597
  year: 1999
  ident: lt24032-bib-0025-20240115
  article-title: Fungal infection and liposomal amphotericin B (AmBisome) therapy in liver transplantation: a 2 year review
  publication-title: J Antimicrob Chemother
  doi: 10.1093/jac/43.4.597
– volume: 28
  start-page: 518
  year: 1998
  ident: lt24032-bib-0023-20240115
  article-title: Cerebral aspergillosis in a liver transplant recipient: a case report of long term survival after combined treatment with liposomal amphotericin B and surgery
  publication-title: J Hepatol
  doi: 10.1016/S0168-8278(98)80329-2
– volume: 26
  start-page: 1092
  year: 1998
  ident: lt24032-bib-0024-20240115
  article-title: Invasive pulmonary aspergillosis due to Aspergillus terreus: 12‐year experience and review of the literature
  publication-title: Clin Infect Dis
  doi: 10.1086/520297
– volume: 83
  start-page: 1408
  year: 2007
  ident: lt24032-bib-0035-20240115
  article-title: Successful treatment of invasive pulmonary aspergillosis after ABO‐incompatible living donor liver transplantation under rapid steroid withdrawal protocol
  publication-title: Transplantation
  doi: 10.1097/01.tp.0000263336.80146.27
– volume: 15
  start-page: 703
  year: 1992
  ident: lt24032-bib-0017-20240115
  article-title: Surgical wound infection by Aspergillus fumigatus in liver transplant recipients
  publication-title: Diagn Microbiol Infect Dis
  doi: 10.1016/0732-8893(92)90074-4
– volume: 6
  start-page: 37
  year: 2004
  ident: lt24032-bib-0031-20240115
  article-title: Deep sinus aspergillosis in a liver transplant recipient successfully treated with a combination of caspofungin and voriconazole
  publication-title: Transpl Infect Dis
  doi: 10.1111/j.1399-3062.2004.00039.x
– volume: 125
  start-page: 2772
  year: 2012
  ident: lt24032-bib-0051-20240115
  article-title: Primary Aspergillus spondylodiscitis in a liver transplant recipient
  publication-title: Chin Med J (Engl)
– volume: 46
  start-page: 327
  year: 2008
  ident: lt24032-bib-0057-20240115
  article-title: Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America
  publication-title: Clin Infect Dis
  doi: 10.1086/525258
– volume: 109
  start-page: 1119
  year: 1996
  ident: lt24032-bib-0021-20240115
  article-title: Transmission of invasive aspergillosis from a subclinically infected donor to three different organ transplant recipients
  publication-title: Chest
  doi: 10.1378/chest.109.4.1119
– volume: 23
  start-page: 608
  year: 1996
  ident: lt24032-bib-0010-20240115
  article-title: Therapeutic outcome in invasive aspergillosis
  publication-title: Clin Infect Dis
  doi: 10.1093/clinids/23.3.608
– volume: 42
  start-page: 1817
  year: 1992
  ident: lt24032-bib-0018-20240115
  article-title: Treatment of cerebral aspergillosis after liver transplantation
  publication-title: Neurology
  doi: 10.1212/WNL.42.9.1817
– volume: 31
  start-page: 344
  year: 1994
  ident: lt24032-bib-0019-20240115
  article-title: Primary cutaneous infection by Aspergillus ustus in a 62‐year‐old liver transplant recipient
  publication-title: J Am Acad Dermatol
  doi: 10.1016/S0190-9622(94)70169-5
– volume: 78
  start-page: 123
  year: 1999
  ident: lt24032-bib-0005-20240115
  article-title: Invasive aspergillosis in transplant recipients
  publication-title: Medicine (Baltimore)
  doi: 10.1097/00005792-199903000-00003
– volume: 65
  start-page: 453
  year: 2012
  ident: lt24032-bib-0004-20240115
  article-title: Clinical epidemiology of 960 patients with invasive aspergillosis from the PATH Alliance registry
  publication-title: J Infect
  doi: 10.1016/j.jinf.2012.08.003
– volume: 12
  start-page: 51
  year: 2010
  ident: lt24032-bib-0047-20240115
  article-title: Severe cerebral aspergillosis after liver transplant
  publication-title: Transpl Infect Dis
  doi: 10.1111/j.1399-3062.2009.00461.x
– volume: 52
  start-page: 813
  year: 2003
  ident: lt24032-bib-0011-20240115
  article-title: Prevention of invasive fungal infections in liver transplant recipients: the role of prophylaxis with lipid formulations of amphotericin B in high‐risk patients
  publication-title: J Antimicrob Chemother
  doi: 10.1093/jac/dkg450
– volume: 41
  start-page: 2933
  year: 2009
  ident: lt24032-bib-0041-20240115
  article-title: Endogenous Aspergillus endophthalmitis occurring after liver transplantation: a case report
  publication-title: Transplant Proc
  doi: 10.1016/j.transproceed.2009.07.008
– volume: 36
  start-page: 2708
  year: 2004
  ident: lt24032-bib-0056-20240115
  article-title: Combined use of sirolimus and voriconazole in renal transplantation: a report of two cases
  publication-title: Transplant Proc
  doi: 10.1016/j.transproceed.2004.09.043
– volume: 41
  start-page: 52
  year: 2005
  ident: lt24032-bib-0007-20240115
  article-title: Risk factors for invasive aspergillosis in solid‐organ transplant recipients: a case‐control study
  publication-title: Clin Infect Dis
  doi: 10.1086/430602
– volume: 2013
  start-page: 928289
  year: 2013
  ident: lt24032-bib-0052-20240115
  article-title: Aspergillus tracheobronchitis causing subtotal tracheal stenosis in a liver transplant recipient
  publication-title: Case Rep Transplant
– volume: 11
  start-page: 868
  year: 2007
  ident: lt24032-bib-0034-20240115
  article-title: Aspergillosis in children after liver transplantation: single center experience
  publication-title: Pediatr Transplant
  doi: 10.1111/j.1399-3046.2007.00754.x
– volume: 48
  start-page: 503
  year: 2009
  ident: lt24032-bib-0058-20240115
  article-title: Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America
  publication-title: Clin Infect Dis
  doi: 10.1086/596757
– volume: 14
  start-page: 375
  year: 1995
  ident: lt24032-bib-0008-20240115
  article-title: Risk factors for systemic fungal infections in liver transplant recipients
  publication-title: Eur J Clin Microbiol Infect Dis
  doi: 10.1007/BF02114892
– volume: 44
  start-page: 370
  issue: suppl
  year: 2001
  ident: lt24032-bib-0028-20240115
  article-title: Coexistent cutaneous Aspergillus and cytomegalovirus infection in a liver transplant recipient
  publication-title: J Am Acad Dermatol
– volume: 22
  start-page: 589
  year: 2009
  ident: lt24032-bib-0042-20240115
  article-title: Successful treatment of invasive sphenoidal, pulmonary and intracerebral aspergillosis after multivisceral transplantation
  publication-title: Transpl Int
  doi: 10.1111/j.1432-2277.2008.00817.x
– volume: 11
  start-page: 175
  year: 2009
  ident: lt24032-bib-0044-20240115
  article-title: Invasive aspergillosis in two liver transplant recipients: diagnosis by SeptiFast
  publication-title: Transpl Infect Dis
  doi: 10.1111/j.1399-3062.2009.00367.x
– volume: 54
  start-page: e220
  year: 2011
  ident: lt24032-bib-0045-20240115
  article-title: Invasive aspergillosis caused by Aspergillus terreus in a living donor liver transplant recipient successfully treated by caspofungin
  publication-title: Mycoses
  doi: 10.1111/j.1439-0507.2009.01829.x
– volume: 36
  start-page: 46
  year: 2003
  ident: lt24032-bib-0003-20240115
  article-title: Trends in risk profiles for and mortality associated with invasive aspergillosis among liver transplant recipients
  publication-title: Clin Infect Dis
  doi: 10.1086/345441
– volume: 61
  start-page: 666
  year: 1996
  ident: lt24032-bib-0006-20240115
  article-title: Incidence and significance of Aspergillus cultures following liver and kidney transplantation
  publication-title: Transplantation
  doi: 10.1097/00007890-199602270-00029
– volume: 33
  start-page: 278
  year: 2014
  ident: lt24032-bib-0059-20240115
  article-title: Invasive aspergillosis among heart transplant recipients: a 24‐year perspective
  publication-title: J Heart Lung Transplant
  doi: 10.1016/j.healun.2013.11.003
– volume: 46
  start-page: 1813
  year: 2008
  ident: lt24032-bib-0014-20240115
  article-title: Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group
  publication-title: Clin Infect Dis
  doi: 10.1086/588660
– volume: 10
  start-page: 333
  year: 2008
  ident: lt24032-bib-0038-20240115
  article-title: Real‐time PCR on the first galactomannan‐positive serum sample for diagnosis invasive aspergillosis in liver transplant recipients
  publication-title: Transpl Infect Dis
  doi: 10.1111/j.1399-3062.2008.00323.x
– volume: 1
  start-page: 465
  year: 2010
  ident: lt24032-bib-0048-20240115
  article-title: Successful, combined long‐term treatment of cerebral aspergillosis in a liver transplant patient
  publication-title: Virulence
  doi: 10.4161/viru.1.5.13110
– volume: 347
  start-page: 408
  year: 2002
  ident: lt24032-bib-0012-20240115
  article-title: Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa020191
– volume: 43
  start-page: 2428
  year: 2011
  ident: lt24032-bib-0050-20240115
  article-title: Invasive pulmonary aspergillosis after living donor liver transplantation should be eradicated or not? A case report
  publication-title: Transplant Proc
  doi: 10.1016/j.transproceed.2011.05.034
– volume: 13
  start-page: 228
  year: 2013
  ident: lt24032-bib-0001-20240115
  article-title: Aspergillosis in solid organ transplantation
  publication-title: Am J Transplant
  doi: 10.1111/ajt.12115
– volume: 39
  start-page: 3505
  year: 2007
  ident: lt24032-bib-0036-20240115
  article-title: A case of successful resection after long‐term medical treatment of invasive pulmonary aspergillosis following living donor liver transplantation
  publication-title: Transplant Proc
  doi: 10.1016/j.transproceed.2007.05.085
– volume: 8
  start-page: 1065
  year: 2002
  ident: lt24032-bib-0030-20240115
  article-title: Risk factors for invasive aspergillosis in liver transplant recipients
  publication-title: Liver Transpl
  doi: 10.1053/jlts.2002.36239
– volume: 64
  start-page: 716
  year: 1997
  ident: lt24032-bib-0002-20240115
  article-title: Invasive aspergillosis in liver transplant recipients in the 1990s
  publication-title: Transplantation
  doi: 10.1097/00007890-199709150-00009
– volume: 20
  start-page: 580
  year: 2014
  ident: lt24032-bib-0060-20240115
  article-title: Improvement in the outcome of invasive fusariosis in the last decade
  publication-title: Clin Microbiol Infect
  doi: 10.1111/1469-0691.12409
– volume: 48
  start-page: 210
  year: 1995
  ident: lt24032-bib-0020-20240115
  article-title: Use of the Pastorex Aspergillus antigen latex agglutination test for the diagnosis of invasive aspergillosis
  publication-title: J Clin Pathol
  doi: 10.1136/jcp.48.3.210
– volume: 42
  start-page: 47
  year: 1999
  ident: lt24032-bib-0026-20240115
  article-title: Systemic mycoses during prophylactical use of liposomal amphotericin B (Ambisome) after liver transplantation
  publication-title: Mycoses
  doi: 10.1046/j.1439-0507.1999.00266.x
– volume: 12
  start-page: 123
  year: 2000
  ident: lt24032-bib-0027-20240115
  article-title: Aspergillus osteomyelitis after liver transplantation: conservative or surgical treatment?
  publication-title: Eur J Gastroenterol Hepatol
  doi: 10.1097/00042737-200012010-00022
– volume: 81
  start-page: 320
  year: 2006
  ident: lt24032-bib-0013-20240115
  article-title: Combination of voriconazole and caspofungin as primary therapy for invasive aspergillosis in solid organ transplant recipients: a prospective, multicenter, observational study
  publication-title: Transplantation
  doi: 10.1097/01.tp.0000202421.94822.f7
– volume: 42
  start-page: 1417
  year: 2006
  ident: lt24032-bib-0053-20240115
  article-title: Diagnosis of invasive aspergillosis using a galactomannan assay: a meta‐analysis
  publication-title: Clin Infect Dis
  doi: 10.1086/503427
– volume: 13
  start-page: 636
  year: 2009
  ident: lt24032-bib-0043-20240115
  article-title: Aspergillus fumigatus endocarditis in a pediatric liver transplant recipient: favorable outcome without cardiac surgery
  publication-title: Pediatr Transplant
  doi: 10.1111/j.1399-3046.2008.00929.x
– volume: 10
  start-page: 482
  year: 2012
  ident: lt24032-bib-0046-20240115
  article-title: Treatment of refractory cerebral aspergillosis in a liver transplant recipient with voriconazole: case report and review of the literature
  publication-title: Exp Clin Transplant
  doi: 10.6002/ect.2012.0028
– volume: 26
  start-page: 1730
  year: 2006
  ident: lt24032-bib-0054-20240115
  article-title: Factors influencing the magnitude and clinical significance of drug interactions between azole antifungals and select immunosuppressants
  publication-title: Pharmacotherapy
  doi: 10.1592/phco.26.12.1730
– volume: 24
  start-page: 1172
  year: 1997
  ident: lt24032-bib-0022-20240115
  article-title: Infectious ocular complications in orthotopic liver transplant patients
  publication-title: Clin Infect Dis
  doi: 10.1086/513655
– volume: 22
  start-page: 508
  year: 2008
  ident: lt24032-bib-0037-20240115
  article-title: Aspergillus flavus myositis in a patient after liver transplantation
  publication-title: Clin Transplant
  doi: 10.1111/j.1399-0012.2008.00801.x
– volume: 53
  start-page: e231
  year: 2006
  ident: lt24032-bib-0032-20240115
  article-title: Aspergillus thyroiditis in a living donor liver transplant recipient
  publication-title: J Infect
  doi: 10.1016/j.jinf.2006.02.007
– volume: 105
  start-page: 66
  year: 2008
  ident: lt24032-bib-0039-20240115
  article-title: Severe Aspergillus endophthalmitis occurring after liver transplantation in an 8‐month‐old baby [in German]
  publication-title: Ophthalmologe
– volume: 166
  start-page: 1379
  year: 1992
  ident: lt24032-bib-0009-20240115
  article-title: Factors associated with invasive lung aspergillosis and the significance of positive Aspergillus culture after liver transplantation
  publication-title: J Infect Dis
  doi: 10.1093/infdis/166.6.1379
SSID ssj0011590
Score 2.3953228
Snippet Invasive aspergillosis (IA) in liver transplant recipients is associated with grave outcomes. We reviewed 116 individual cases reported in the literature from...
SourceID proquest
pubmed
crossref
wiley
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 204
SubjectTerms Adult
Amphotericin B - therapeutic use
Aspergillosis - therapy
Aspergillus flavus
Aspergillus fumigatus
Cohort Studies
Female
Humans
Kaplan-Meier Estimate
Liver Failure - complications
Liver Failure - surgery
Liver Transplantation
Male
Middle Aged
Probability
Proportional Hazards Models
Renal Insufficiency - complications
Transplant Recipients
Treatment Outcome
Voriconazole - therapeutic use
Title Invasive aspergillosis in liver transplant recipients: Epidemiology, clinical characteristics, treatment, and outcomes in 116 cases
URI https://onlinelibrary.wiley.com/doi/abs/10.1002%2Flt.24032
https://www.ncbi.nlm.nih.gov/pubmed/25348192
https://www.proquest.com/docview/1647751015
https://www.proquest.com/docview/1652428536
Volume 21
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT-MwELYQB8SFx7JAF1gZabV7aUqT2E7NDa1aAaJ7WLVSpT1EtuOgiihFmxQJrvxxZpwH6j4kxCmKMhk7Gc_4sz3-TMiXvkiFiDC7gTPtMZ5ITwsTeT63EtAEA1COA8XxD3E5ZdczPquzKnEvTMUP0U64oWe4eI0OrnRx9koampU95JLD8IupWoiHfrbMUYBz3PQKHtrqCSZ4wzvbD86aF1d7or_g5Spadd3NaJv8aipaZZnc9Zal7pmnPzgc3_clO2SrRqH0omo2u2TN5h_IxrheZ98jz1f5g8LEdqqQSfx2nmWLYl7QeU4zTOSgpeNEz8AsFOkx7nFXZXFOh6_nzT52abPrkppVVugubdPbu1TlCV0sS6izdfp9X1ADXWvxkUxHw8n3S68-rsEziAI8GUkjAH4oDlelwkEQRRxufTMQWoWJL5llzEolkZOurwNtBqFNAp6C_UyfhftkPV_k9pDQMDVpAjrDKIUIE4Q6GcDARyrDVMiV8DvkW2O62NRc5nikRhZXLMxBnJWx-6cdctpK3lf8Hf-QOW6sH9ceXMTIsxZhwOKgon0MvocLKiq3iyXKcEA4AHhEhxxUraYtJOC4xVmC8q_O9v8tPb6ZuOuntwoekU1AbbxKHT8m6-XvpT0BZFTqz84HXgDZQgfO
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB5VrQRcWp7tlgJGQnDZbDfxI2s4IdRqC7s9oK3UA1LkOA5aEWWrJosEV_44M86jWh4S4hRFmdhOxmN_tme-AXgxVrlSMXk3SJEGQmY6SJWNg1A6jWhCICinheL8XE0vxPtLebkFb7pYmIYfot9wI8vw4zUZOG1IH9-whhb1iMjkcPzdoYTefj31seeOQqTjN1gobWugUKBjnh1Hx92bm3PRbwBzE6_6Ced0Dz51TW38TL6M1nU6st9_YXH8z2-5C7stEGVvm55zD7ZceR9uzduj9gfw46z8asi3nRkiE_-8LIpVtazYsmQF-XKw2tOiF6gZRgwZVxRYWb1mJzcpZ78NWRd4yewmMfSQ9R7uQ2bKjK3WNTba-fLDUDGLs2v1EC5OTxbvpkGbsSGwBAQCHWurEIEYiVdj-CSKY4m3oZ2o1PAs1MIJ4bTRREs3TqPUTrjLIpmHXNmx4I9gu1yV7gAYz22eYZk8znGQiXiaTXDto40VhkujwgG86nSX2JbOnLJqFElDxBwlRZ34fzqA573kVUPh8QeZo079SWvEVUJUazGNWRKL6B-j-dGZiindak0yEkEOYh41gP2m2_SVRJKinDUW_tIr_6-1J7OFvx7-q-AzuD1dzGfJ7Oz8w2O4gyBONp7kR7BdX6_dEwRKdfrUG8RPSlcL6Q
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9wwEBYlhdBL32k23bYKhPSy3rWth63eSjdLkiahlAQCORhZlsNS411ib6G99o93Rn6E7QNCTsZ4PJI9GumTNPqGkD1f5lJGGN0geOpxkSkvlSbyAmEVoAkOoBwniqdn8vCCH1-KyzaqEs_CNPwQ_YIbeobrr9HBl1k-uSUNLeoxcslB9_uQSz_GFj392lNHAdBx6yuYtdWTXIqOeNYPJ92b60PRX_hyHa668Wb2hFx1NW3CTL6NV3U6Nj__IHG836c8JY9bGEo_Nu3mGXlgy-dk87TdaH9Bfh2V3zVGtlONVOLX86JYVPOKzktaYCQHrR0pegF2ociPscRjldUHenCbcPbHiHbHLqlZp4Ue0T6-fUR1mdHFqoY6W6c_CCQ1MLZWL8nF7OD806HX5mvwDMIAT0XKSMAfWsBVaxaHUSTgNjCxTDXLAsUt51ZphaR0fhqmJmY2C0UeMGl8zrbIRrko7TahLDd5BjpZlEMXE7I0i2Hmo7ThmgktgwF535kuMS2ZOebUKJKGhjlMijpx_3RAdnvJZUPg8Q-ZYWf9pHXhKkGitQh7LAEq-sfgfLijoku7WKGMAIgDiEcOyKum1fSFhALPOCtQvu9s_9_Sk5Nzd925q-A7svllOktOjs4-vyaPAMGJJox8SDbqm5V9AyipTt86d_gNOw4KoQ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Invasive+aspergillosis+in+liver+transplant+recipients%3A+epidemiology%2C+clinical+characteristics%2C+treatment%2C+and+outcomes+in+116+cases&rft.jtitle=Liver+transplantation&rft.au=Barchiesi%2C+Francesco&rft.au=Mazzocato%2C+Susanna&rft.au=Mazzanti%2C+Sara&rft.au=Gesuita%2C+Rosaria&rft.date=2015-02-01&rft.issn=1527-6473&rft.eissn=1527-6473&rft.volume=21&rft.issue=2&rft.spage=204&rft_id=info:doi/10.1002%2Flt.24032&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1527-6465&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1527-6465&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1527-6465&client=summon